id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
CMS-2020-0072-30224,CMS,CMS-2020-0072,"Medicaid Program: Establishing Minimum Standards in Medicaid State Drug Utilization Review and Supporting Value-Based Purchasing for Drugs Covered in Medicaid, etc.; Delays of Effective and Inclusion Dates",Proposed Rule,,2021-05-28T04:00:00Z,2021,5,2021-05-28T04:00:00Z,2021-06-29T03:59:59Z,2021-06-29T01:00:17Z,2021-11160,0,0,0900006484b40e06
CMS-2020-0072-0001,CMS,CMS-2020-0072,"Medicaid Program: Establishing Minimum Standards in Medicaid State Drug Utilization Review and Supporting Value-Based Purchasing for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability Requirements",Proposed Rule,,2020-06-19T04:00:00Z,2020,6,2020-06-19T04:00:00Z,2020-07-21T03:59:59Z,2020-08-05T01:02:08Z,2020-12970,0,0,09000064846fa802